Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- SERENEIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis: primary endpoint results, effect…
- SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery: Complete Statistical AnalysisIndependent statistical analysis of SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): Complete Statistical AnalysisIndependent statistical analysis of Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04508725).
- Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: Complete Statistical AnalysisIndependent statistical analysis of Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05972733).
- Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Seroquel XR in Adults With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Seroquel XR in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852631).
- Serratus Plane Block for Postoperative Pain Control: Complete Statistical AnalysisIndependent statistical analysis of Serratus Plane Block for Postoperative Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02865928).
- Sert2Independent statistical analysis of A Trial of Sertraline in Young Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity: Complete Statistical AnalysisIndependent statistical analysis of Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04966741).
- Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: Complete Statistical AnalysisIndependent statistical analysis of Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00837824).
- Severing Nuchal Cord at the Time of Delivery.: Complete Statistical AnalysisIndependent statistical analysis of Severing Nuchal Cord at the Time of Delivery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00345254).
- Sex Differences in the Dilatory Response of Compound 21: Complete Statistical AnalysisIndependent statistical analysis of Sex Differences in the Dilatory Response of Compound 21: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05576155).
- Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid: Complete Statistical AnalysisIndependent statistical analysis of Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SFA ISRIndependent statistical analysis of Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SFPATIndependent statistical analysis of Sinusitis and Facial Pain Disorders Anti-Depression Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00754793).
- SGA-POWERIndependent statistical analysis of Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SGI-110Independent statistical analysis of SGI-110 in Combination With Carboplatin in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01696032).
- SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction: Complete Statistical AnalysisIndependent statistical analysis of SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SGLT2iIndependent statistical analysis of SGLT2 Inhibition in Older Obese Adults With Pre-diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04401904).
- SHARE Project Define: Complete Statistical AnalysisIndependent statistical analysis of SHARE Project Define: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06125509).
- Shared Decision Making About Medication Use for People With Multiple Health Problems: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making About Medication Use for People With Multiple Health Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: Complete Statistical AnalysisIndependent statistical analysis of Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337203).
- SHARPIndependent statistical analysis of SHARP, the randomized phase 3 study of sorafenib versus placebo in patients with advanced hepatocellular carcinoma, including its overall survival and symptomatic progression endpoints, stratified log-rank methodology, interim…
- SHARPIndependent statistical analysis of Efficacy of a Multimodal Brain Health Intervention for Older African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHARPIndependent statistical analysis of SpHincterotomy for Acute Recurrent Pancreatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03609944).
- SHARPIndependent statistical analysis of Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHARPENIndependent statistical analysis of SHARPEN - Parkinson's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05987540).
- SHARPSIndependent statistical analysis of Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHELTERIndependent statistical analysis of Transplanting Hepatitis C Lungs Into Negative Lung Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03724149).
- SHIELDIndependent statistical analysis of 38 Week Extension Study to CAIN457C2303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01093846).
- SHIELDIndependent statistical analysis of Phase III Study in Refractory Behcet's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00995709).
- SHIELD-4Independent statistical analysis of An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: Complete Statistical AnalysisIndependent statistical analysis of Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06250738).
- Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection: Complete Statistical AnalysisIndependent statistical analysis of Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SHINEIndependent statistical analysis of Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SHINEIndependent statistical analysis of Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: Complete Statistical AnalysisIndependent statistical analysis of SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03328949).
- Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650128).
- ShOReIndependent statistical analysis of OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757610).
- Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: Complete Statistical AnalysisIndependent statistical analysis of Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators: Complete Statistical AnalysisIndependent statistical analysis of Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02238028).
- Short-term Health Effects of Wild Blueberry Juice Consumption: Complete Statistical AnalysisIndependent statistical analysis of Short-term Health Effects of Wild Blueberry Juice Consumption: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139878).
- Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD): Complete Statistical AnalysisIndependent statistical analysis of Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SICAS-1Independent statistical analysis of Allergens in Inner-City Schools and Childhood Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01756391).
- Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03141905).